Maryam Rachmawati Sumitra

Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines

Bashir Lawal, Yen‐Lin Liu, Ntlotlang Mokgautsi et al. · Biomedicines · 2021 · 52 citations · Full text

Medicine, Oncology, Pharmacology +14

mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications

Bashir Lawal, Ching‐Yu Lee, Ntlotlang Mokgautsi et al. · Frontiers in Oncology · 2021 · 51 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation

Vijesh Kumar Yadav, Yan‐Jiun Huang, Thomashire A. George et al. · Cancers · 2020 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential GSK3β/β-Catenin/STAT3/CD44 Suppressor with Anti-Glioblastoma Properties

Ntlotlang Mokgautsi, Ya-Ting Wen, Bashir Lawal et al. · International Journal of Molecular Sciences · 2021 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of CCND1/CDK4/PLK1/CD44 in Cancer Types

Ntlotlang Mokgautsi, Yu‐Chi Wang, Bashir Lawal et al. · Cancers · 2021 · 27 citations · Full text

Medicine, Bioinformatics, Pharmacology +17